retatrutide dosing schedule phase 2 trial Dosage for Weight Loss (Chart Included) retatrutide dosing schedule phase 2

Nausea, diarrhea, vomiting, constipation, abdominal discomfort, indigestion, bloating, and reflux appear prominently in current prescribing information for semaglutide and tirzepatide

Clinical research demonstrates this synergy across multiple populations

Neither medication has been studied in clinical trials at microdose levels

People who strongly prefer oral medication, travel frequently, or dislike injections may lean toward tablets

Over time, chronic energy deficiency can lead to fatigue, poor recovery, loss of muscle, hormonal disturbances, low energy availability and impaired performance a condition akin to RED-S (Relative Energy Deficiency in Sport)